George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Topped up for $73
Previous posts on 0Y3M last 10/3/23.
This did go up according to ( D ) Chart last year after my post 3/2/2023.
Still shows a 9.4% spread today.
Might be of interest .
See this on days risers this morning up 4.23% but spread 10.52%.
Had a sell order on below my target price at $87.5..... 17/1/24 wanting to raise cash it failed.
I am not lucky with shares .
Big fall yesterday over 10% on drug failure RNS could buy for$78.5
3/10/23 low 73.27
9/3/23 topped up @ $79.5
02/12/2022 @ $89 * the new high
4/8/22 price dropped to *62.18
26th May 2022 year high $65
1st buy 21/4/20 @ 79.. sold it 29/4/20 for 81
More buys in 2020 for 78, 74, 73, 70, 68,
30/11/22 Sold $ 87 five year high .
20/1/23 Bought back 28 for 82.6.
9/3/23 1/2 again 79.5
Might be of interest .
See this on days risers this morning up 4.23% but spread 10.52%.
A cursory glance at the Remdesivir data shows a modest benefit for recovery times. A slightly more in depth look and you will see that the Remdesivir arm consisted of younger and less comorbid patients... There is no convincing evidence for this drug in humans for any coronavirus. The hype, US hoarding, and current share price are entirely unwarranted. Strong sell for me.
News says this morning that the USA has bought up nearly the whole worlds supply of Remdesivir.
market would love a Pharma MergerToday
in my opinion
both companies are doing a great job i think a merger will benefit both sides
i dont think any cash will be involved but paper stock
a 100 % paper merger will be welcomed by the world StockMarkets
i feel that both stocks can gap up 15-25%
bearing in mind that pharma stocks did not make any headway in the last few weeks of the stock market ROCKET UP PERFORMANCE
They will need to catch up
I think AZN will open over £10 with Gilead Stocks Opening over $100 in NewYork
I WONDER IF THE SHORTERS WILL GET COUGHT OUT
Yes i think it will still be a while yet before anything major will happen.
Thanks for that Dodgiedealer I see why now.
Has anyone read this article .... Maybe it has something to do with the lack of movement ... ?
https://theintercept.com/2020/05/26/coronavirus-gileand-remdesivir-treatment/
So why has this not gone into orbit today ?
Remdesivir, an antiviral originally designed to fight ebola, is the only drug shown to have any effect in combating Covid-19. It will soon be available to some of those in greatest need, Matt Han****, the health secretary, announced yesterday.
Haha, I didn't put those **** in my previous post. How else am I supposed to say his name??
Matt Han**** has just stated in the briefing, that Remdesivir is a major step forward.
Shared from Sky News: Coronavirus: NHS to treat severe COVID-19 patients with Ebola drug to speed up recovery https://news.sky.com/story/coronavirus-nhs-to-treat-severe-covid-19-patients-with-ebola-drug-to-speed-up-recovery-11994848
Featured on BBC news this evening after Gilead Sciences has signed non-exclusive voluntary licensing agreements with five generic drug makers based in India and Pakistan on anti-viral drug Remdesivir, seen as a potential therapy for COVID19.
Indian companies Cipla Ltd, Hetero Labs Ltd, Jubilant Life Sciences and Mylan and Pakistani firm Ferozsons Laboratories has signed the commercial agreement that allows the companies to manufacture remdesivir for distribution in 127 countries, including India.
Apologies if this is old news as this may have been in the news around lunchtime today, but thought i would share all the same.
GLA.
Thanks Eccles. I will set my limit and give it a whirl! Thanks again.
It's just lucky if you can get in early in morning .or set a limit buy .
If we are lucky to buy in Frist thing Monday we could have a good day .if you set a limit buy at what price do you set it at .last time I done that I miss out by one pence so it's up to you good luck any way .
I just saw this. FDA approval? It will go CRAZY!
Everytime I see something like this and try to make some money, I get spiked! Any tips to avoid this, apart from getting in earlier?!
?at what price will this open on Monday. with news out today . Up early on Monday for me try make do money .
Shinfalls, this is not a magic bullet by any means. However, a reduction in recovery time of 27% is a major improvement I would say in the grand scheme of things. Cost of treating someone per day, loss of productivity per day, medication, etc, etc.
MS
Now with correct name in title
https://www.bbc.com/news/health-52478783
MS